FIELD: biotechnology.
SUBSTANCE: present invention relates to polypeptides, which are complement activity modulators. Polypeptides show C5-inhibitory activity.
EFFECT: obtaining polypeptides for complement activity modulation.
11 cl, 7 dwg, 18 tbl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
MODULATION OF COMPLEMENT ACTIVITY | 2015 |
|
RU2670988C2 |
PEPTIDIC INTERLEUKIN-23 RECEPTOR INHIBITORS FOR ORAL ADMINISTRATION AND USE THEREOF FOR TREATING INFLAMMATORY INTESTINAL DISEASES | 2015 |
|
RU2736637C2 |
KV1_3 BLOCKERS | 2020 |
|
RU2825633C1 |
GIP AGONIST COMPOUNDS AND METHODS | 2015 |
|
RU2716985C2 |
MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF | 2020 |
|
RU2816492C2 |
STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION | 2016 |
|
RU2740672C2 |
ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
MOLECULES THAT BIND BCMA AND USE OF SUCH MOLECULES | 2019 |
|
RU2812322C2 |
MODIFIED LIPIDATED RELAXIN B-CHAIN PEPTIDES AND THEIR THERAPEUTIC USE | 2019 |
|
RU2804702C2 |
ANTIBODIES THAT BIND TUMOR TISSUE FOR DIAGNOSIS AND TREATMENT | 2020 |
|
RU2806915C2 |
Authors
Dates
2022-08-22—Published
2015-06-12—Filed